6Barry CE 3rd, Boshoff HI, Dartois V, Dick T, Ehrt S, Flynn J, Schnappinger D, Wilkinson RJ, Young D. The spectrum of latent tuberculosis, rethinking the biology and intervention strategies [J]. Nat Rev Microbiol, 2009, 7 (12), 845-855.
7Mazurek GH, Jereb J, Lobue p, Iademarco MF, Metchock B, Vernon A; Division of Tuberculosis Elimination, National Center for HIV, STD, and TB Prevention, Centers for Disease Control and Prevention (CDC). Guidelines for using the QuantiFERON-TB Gold test for detecting Mycobacterium tuberculosis infection, United States [J]. MMWR Recomm Rep, 2005, 54 (RR-15), 49-55.
8Dogra S, Narang P, Mendiratta DK, Chaturvedi r. Reingold AL, Colford JM Jr, Riley LW, Pai M. Comparison of a whole blood interferon-gamma assay with tuberculin skin testing for the detection of tuberculosis infection in hospitalized children in rural India [J]. J Infect, 2007, 54(3), 267-276.
9Connell TG, Ritz N, Paxton GA, Buttery JP, Curtis N, Ranganathan SC. A three-way comparison of tuberculin skin testing, QuantiFERON-TB gold and T-SPOT. TB in children [J]. PLoS One, 2008,3(7), e2624.
10Detjen AK, Keil T, Roll S, Hauer B, Mauch H, Wahn U, Magdorf K. Interferon-gamma release assays improve the diagnosis of tuberculosis and non tuberculous mycobacterial disease in children in a country with a low incidence of tuberculosis [J]. Clin Infect Dis, 2007, 45(3), 322-328.
